Asia Pacific Over-The-Counter (OTC) Drugs Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Published : 30 Aug 2024

Report Type : Regional

Share This On

Download Free Sample Now Buy This Report

Home > Reports > Pharmaceuticals > Healthcare > Asia Pacific Over-The-Counter (OTC) Drugs Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Description Table of Contents Scope of the Report

Asia Pacific Over-The-Counter (OTC) Drugs Market - Size

Study Period

2018 - 2030

Base Year For Estimation

2023

Forecast Data Period

2024-2030

Historical Data Period

2018-2021

CAGR

7 %

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Over-the-counter(OTC) medicine is also known as OTC or nonprescription medicine. All these terms refer to that medicine because you can buy without a prescription. They are safe and effective when you follow the directions on the label and as directed by your healthcare professional.

Asia-Pacific Over-the-Counter (OTC) Drugs Market Share:

Compared to the past years, Over-the-Counter devices have undergone a predominant change in the markets of Asia-Pacific. The Product Type segment is expected to have the highest growth rate.

Asia-Pacific Over-the-Counter (OTC) Drugs Market Size & Growth:

The Asia-Pacific OTC drugs market was valued at USD XX million in 2018 and is projected to reach a value of USD XX million by 2024, registering a CAGR of XX%, during the forecast period 2018-2024.

There is a wide range of Products in Over-the-Counter Drugs Market such as Cough and Cold, Vitamin, Minerals and Supplements, Analgesics, and Digestive Products. Australia, India, and China have the largest share market. Japan is also an emerging market

Asia Pacific Over-The-Counter (OTC) Drugs Market - Growth

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

that has scope for growth and can potentially dominate the market in the future.

Product Innovation, Increasing distribution channels for OTC drugs, Pharmaceutical companies switching to OTC from Rx drugs, Ease in advertising restrictions for these OTC drugs are significant factors that propel or drive the growth of Spain Over-the-Counter(OTC) Drugs market.

Asia-Pacific Over-the-Counter (OTC) Drugs Market Industry Analysis:

The Asia-Pacific Over-the-Counter Drugs market has been segmented by product type, which is sub-segmented into digestive products, vitamins, minerals and supplements, analgesics, cough and cold, and others.

Asia-Pacific Over-the-Counter (OTC) Drugs Market Outlook:

Incorrect self-diagnosis and Concerns regarding the probability of substance abuse of OTC drugs are the two major factors responsible for the hampering of the OTC market growth.

Asia-Pacific Over-the-Counter (OTC) Drugs Market Trends:

Daiichi Sankyo Company, Limited and Puma Biotechnology, Inc. have announced a preclinical research collaboration with Memorial Sloan Kettering Cancer Center (MSK) to explore the combination of Daiichi Sankyo’s investigational antibody-drug conjugate DS-8201 and Puma Biotechnology’s irreversible pan-HER

You can also purchase parts of this report. Do you want to check out a section wise price list

Asia Pacific Over-The-Counter (OTC) Drugs Market - Porter's Five Force Analysis

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

tyrosine kinase inhibitor neratinib (NERLYNX®) in HER2-mutated or HER2-positive solid tumours. Takeda and Denali Therapeutics Collaborate to Develop and Commercialize Therapies for Neurodegenerative Diseases

Asia-Pacific Over-the-Counter (OTC) Drugs Market Research report includes:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
Identify the latest developments, market shares and strategies that are employed by the major market players, such as
Daiichi Sankyo Co Ltd
Takeda Pharmaceutical Co Ltd
Astellas Pharma Inc
Mitsubishi Tanabe Pharma Corp
Eisai Co Ltd

Exclusive Benefits

Credibility and
Transparency

We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.

Exhaustive
Coverage

Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.

Competitive
Edge

Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.

Golden
pportunities

Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.

Top-notch Reportsd
Guaranteed

Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.

Post Purchase
Support

Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.